CytoMed Therapeutics Limited

GDTC·NasdaqCM·Healthcare
Compare
0.8890−0.0210 (−2.31%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.9100
Open0.8309
Day range0.83090.8918
52-week range0.68003.1000
Off day high−0.31%
Off 52-week high−71.32%
Volume6.38K
Avg. volume (3M)19.40K
Market cap10.61M
EPS (TTM)-0.2300
Forward P/E-5.93
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.02
Shares outstanding11.93M
Short interest0.54% of float
Earnings dateApr 28, 2025
Analyst target4.1600
Profit margin0.00%

Against its peers

Compare in full ›
GDTC INAB SNTI TCRX CYP.AX IMMP
Market cap 10.61M 9.18M 6.79M 14.23M 4.38M 21.74M
P/E (TTM) — — — — — —
Forward P/E -5.9 -1.0 -0.2 -0.4 -0.2 -0.9
Price/book 2.7 0.5 -1.6 0.2 -6.5 0.5
Dividend yield — — — — — —
1-year change −56.87% −41.72% −90.82% −83.35% −94.47% −91.38%
Today −2.31% −2.02% −0.73% +11.11% 0.00% −1.50%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All GDTC news ›
Stock Titan·

CytoMed Therapeutics chairman reports 25.17% stake

The chairman bought 29,250 shares in CytoMed Therapeutics (NASDAQ: GDTC) and reported his stake. Stock Titan - [SCHEDULE 13D/A] CytoMed Therapeutics Ltd Amended Major Shareholder Report CytoMed Therapeutics chairman reports 25.17% stake…

Stock Titan·

CytoMed Therapeutics chairman buys 62,000 shares

CytoMed Therapeutics (NASDAQ: GDTC) chairman buys shares, reports a 24.92% stake. Stock Titan - [SCHEDULE 13D/A] CytoMed Therapeutics Ltd Amended Major Shareholder Report CytoMed Therapeutics chairman buys 62,000 shares His reported…

From the 4Search news index, newest first.

In the news

4mentions in 30 days
4with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance